Solu Therapeutics

We had an amazing off-site event last week, filled with activities that strengthened our bonds and reinforced our shared goals. The day kicked off with engaging ice breakers and meaningful discussions around Solu’s mission and values. It was great to see everyone so involved and passionate about what we stand for. In the afternoon, we headed to the Museum of Science in Cambridge for an exciting scavenger hunt. With three teams competing, there was plenty of camaraderie and friendly competition. We wrapped up the day at Lamplighter Brewing Co., enjoying some well-deserved refreshments. It was the perfect way to celebrate our Solu spirit and achievements.

Our co-founder and CTO, Brandon Turunen, PhD, is speaking at the 4th Annual Induced Proximity-Based Drug Discovery Summit today in Boston. Brandon will showcase the development of the CyTAC™ and TicTAC™ platforms and discuss PK/PD and in vivo efficacy in mice and non-human primates. For event details, visit: https://lnkd.in/dQvHPMG7 #CyTACPlatform #DrugDevelopment #Biotechnology #ChemicalInducedProximity #TargetedTherapies #Biopharma #TherapeuticDevelopment #CellTherapy #MedicalBreakthroughs #FutureOfMedicine #PrecisionMedicine

Our co-founder and CTO, Brandon Turunen, PhD, is speaking at the 4th Annual Induced Proximity-Based Drug Discovery Summit today in Boston. Brandon will showcase the development of the CyTAC™ and TicTAC™ platforms and discuss PK/PD and in vivo efficacy in mice and non-human primates. For event details, visit: https://lnkd.in/dQvHPMG7 #CyTACPlatform #DrugDevelopment #Biotechnology #ChemicalInducedProximity #TargetedTherapies #Biopharma #TherapeuticDevelopment #CellTherapy #MedicalBreakthroughs #FutureOfMedicine #PrecisionMedicine

Later this month, Brandon Turunen, PhD, our co-founder and Chief Technical Officer, will be speaking at the 4th Annual Induced Proximity-Based Drug Discovery Summit in Boston, MA. Brandon will showcase Solu’s innovative CyTAC™ and TicTAC™ platforms and the potential to optimize efficacy against GPCRs and ion channels that were previously difficult or impossible to drug with other therapeutic modalities. To learn more about the event, visit: https://lnkd.in/dQvHPMG7   #CyTACPlatform #InnovativeMedicine #DrugDevelopment #Biotechnology #ChemicalInducedProximity #TargetedTherapies #Biopharma #TherapeuticDevelopment #CellTherapy #MedicalBreakthroughs #FutureOfMedicine #PrecisionMedicine 

Today and every day, we embrace unity and strive to create an inclusive, diverse and welcoming workplace. Please join us in celebrating freedom in recognition of #Juneteenth. 

Solu is a great company with exciting technology. Highly recommend investigating opportunities with Solu.

Attending #BIO2024 this week? Meet with Michael Boretti and John Pribis to learn more about Solu’s innovative approach to unlocking previously inaccessible targets using our CyTAC™ platform and a deep pipeline spanning #oncology, #immunology, and pain indications. The BIO International Convention is the largest and most comprehensive event for #biotechnology executives, leaders, and investors. Connect with us in San Diego and through BIO’s One-on-One Partnering™ platform: https://lnkd.in/eEDtKaAK #CyTACPlatform #InnovativeMedicine #DrugDevelopment #Biotechnology #TargetedTherapies #Biopharma #TherapeuticDevelopment #CellTherapy #MedicalBreakthroughs #FutureOfMedicine #PrecisionMedicine 

Last week marked our 1-year anniversary here at Solu Therapeutics. In just 12 months, we've made incredible strides in building our CyTAC™ platform and a deep pipeline across oncology, immunology, and chronic pain. The team has worked extremely hard to put us in a position to be in the clinic early next year and continue to advance towards our goal of creating a new generation of medicines that transform patients’ lives. As we reflect on the past year, we're filled with gratitude for all who have supported us – our team, investors, partners, and the broader healthcare community. Here's to a year of remarkable achievements, and to many more years of innovation, collaboration, and meaningful impact on patients’ lives. #CyTACPlatform #DrugDevelopment #Biotechnology #TargetedTherapies #Biopharma #TherapeuticDevelopment #CellTherapy #MedicalBreakthroughs #FutureOfMedicine #Oncology

At Solu Therapeutics, we recognize that strong teamwork is mission-critical for the success of the medicines we develop using our innovative CyTaC™ therapeutic platform. We believe that striking a balance between hard work and fun is key to our continued success. Our recent axe-throwing event went beyond aiming for bullseyes; it was a celebration of the camaraderie and spirit that drive us forward. Here’s to hitting our targets, in the lab and beyond! #TeamSolu #Biotech

We are thrilled to welcome Michael Boretti, Ph.D., as our new Chief Business Officer at Solu Therapeutics! 🎉 With over 15 years of experience in strategic biotechnology leadership, Mike is perfectly positioned to spearhead our business development, alliance management, and strategic financing activities.   Under Mike’s guidance, we’re looking forward to unlocking new potential with our proprietary CyTaCTM platform and advancing our pipeline of transformative targeted medicines. Mike’s impressive track record in company-building and deal-making is invaluable as we aim to impact the lives of patients facing disease.   Join us in welcoming Mike to the Solu family!   #SoluTherapeutics #Biotech #Leadership #CyTaC https://lnkd.in/ezDZaWKw